June 2010
BioWorld Today;6/7/2010, Vol. 21 Issue 108, p6
This section offers news briefs concerning finances of biotechnology companies, which include the repurchase of outstanding common stock by BioSpecifics Technologies Corp. and the filing of a registration statement by Lorus Therapeutics Inc.


Related Articles

  • Investor throws BioSpecifics a lifeline. Schachter, Ken // Long Island Business News (7/1993 to 5/2009);6/27/2003, Vol. 50 Issue 27, p5A 

    Reports on the private placement of securities for BioSpecifics Technologies Corp., a biotechnology firm. Repayment of a loan to Bio Partners LLP, an investor; Product to treat bedsores; Regulatory approval sought from the United States Food and Drug Administration.

  • Financings Roundup.  // BioWorld Today;11/11/2010, Vol. 21 Issue 219, p4 

    The article presents an update on the financing efforts of several biotechnology companies as of November 11, 2010, including Biodesix Inc., Cerus Corp. and Lorus Therapeutics Inc.

  • Financings Roundup.  // BioWorld Today;8/16/2011, Vol. 22 Issue 158, p7 

    The article reports that Lorus Therapeutics Inc. of Toronto, Canada completed its offering of 5.5 million units prices at 40Canadian cents apiece for a gross proceeds of 2.2 million Canadian dollars.

  • Other News To Note.  // BioWorld Today;2/8/2011, Vol. 22 Issue 26, p7 

    This section offers news briefs on the biotechnology industry. BioSpecifics Technologies Corp. has amended its rights agreement to increase the ownership threshold for determining acquiring person status from 15% to 18%. A 2.7 million euros grant was awarded by the Flemish agency for Innovation...

  • Biospecifics adopts poison pill defense. Schachter, Ken // Long Island Business News (7/1993 to 5/2009);5/24/2002, Vol. 49 Issue 22, p4A 

    Reports on the takeover defense adopted by Biospecifics Technologies Corp. in Lynbrook, New York. Shares of executives Tom and Edwin Wegman in the company; Market capitalization of the company stocks.

  • Financings Roundup.  // BioWorld Today;9/30/2010, Vol. 21 Issue 189, p7 

    This article reports on a final prospectus filed by Lorus Therapeutics Inc. for a rights offering of an aggregate five million shares.

  • Financings Roundup.  // BioWorld Today;6/22/2011, Vol. 22 Issue 120, p4 

    The article reveals the plan of Lorus Therapeutics Inc. to raise gross proceeds of at least two million U.S. dollars via a best efforts offering of units.

  • Untitled.  // BioWorld Today;11/25/2013, Vol. 24 Issue 227, p4 

    The article reports on the increase in shares being offered by pharmaceutical firm Lorus Therapeutics Inc. in November 2013.

  • Financings Roundup.  // BioWorld Today;12/1/2009, Vol. 20 Issue 230, p4 

    This article reports that Lorus Therapeutics Inc. has successfully raised 2.46 million Canadian dollars via a private placement of stock and warrants.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics